Back to Hudson Bay Capital Management LP Hudson Bay Capital Management LP

MDNAFMDNAF
6 quarters

Position history for Hudson Bay Capital Management LPHudson Bay Capital Management LP's holdings in Medicenna Therapeutics Corp.

Hudson Bay Capital Management LP previously held 0 shares of MDNAF (Medicenna Therapeutics Corp.), worth $0 as of 2023-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$830,000

Total Shares Change

-1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q4
Latest
Exited
0
-100.0%
$00.0%$0.31
0
2023-Q3
Increased
1.6M
+100.0%
$446,3260.0%$0.29
39
2023-Q2
Decreased
780,564
-52.6%
$373,8900.0%$0.52
0
2023-Q1
Increased
1.6M
+76.4%
$1.1M0.0%$0.61
38
2022-Q4
Decreased
934,347
-6.6%
$439,1430.0%$0.46
0
2022-Q3
New
1M
-
$830,0000.0%$0.81
34

Other major holders of MDNAF: Verition Fund Management LLC, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used